Germline Mutations of theBRCA1andBRCA2Genes in a Breast and Ovarian Cancer Patient

By Randall T.C.   Bell K.A.   Rebane B.A.   Rubin S.C.   Boyd J.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 432-434

Elsevier

Access to resources Recommend Favorite

Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

By Lin Y.-W.   Chen C.-H.   Huang G.-T.   Lee P.-H.   Wang J.-T.   Chen D.-S.   Lu F.-J.   Sheu J.-C.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1789-1795

Elsevier

Access to resources Recommend Favorite

Founder BRCA 1 and 2 Mutations among a Consecutive Series of Ashkenazi Jewish Ovarian Cancer Patients

By Tobias D.H.   Eng C.   McCurdy L.D.   Kalir T.   Mandelli J.   Dottino P.R.   Cohen C.J.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 148-151

Elsevier

Access to resources Recommend Favorite

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

By Beller U.   Halle D.   Catane R.   Kaufman B.   Hornreich G.   Levy-Lahad E.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers

By      

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1710-1718

Spandidos Publications

Access to resources Recommend Favorite